AATMAJ2024-07-012024-09-30 AATMAJ2024-07-012024-09-30in-bse-fin:OneOperatingExpenses01Member AATMAJ2024-09-30 AATMAJ2024-07-012024-09-30 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 0 AATMAJ NOTLISTED INE0OB201016 Aatmaj Healthcare Limited Nonbanking Format SME/ITP 2024-04-01 2025-03-31 2024-11-12 2024-11-05 INR Lakhs Half yearly Single segment HEALTHCARE 17:00:00 17:45:00 2024-11-12 2024-11-12 true Cash Flow Indirect Not applicable 2024-04-01 2024-09-30 Unaudited Standalone 85080000.00 7572000.00 92652000.00 13529000.00 0.00 0.00 23817000.00 3746000.00 4709000.00 43570000.00 89371000.00 3281000.00 0.00 3281000.00 0.00 3281000.00 0.00 3064000.00 3064000.00 217000.00 0.00 0.00 0.00 217000.00 217000.00 113000000.00 5 0.14 0.14 0.00 0.00 0.00 1. The above standalone financial results of the company (“the statement”) have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at its Meeting held on November 12, 2024 and have been subjected to limited review by the statutory auditors of the company on which the auditors have been expressed an unmodified Opinion. 2. The Standalone Financial results has been prepared in accordance with recognition and measurement principles laid down in the Accounting Standard 25 “Interim Financial Reporting” (As 25) as prescribed under section 133 of the companies act, 2013 (“the Act”) read with the companies (accounting standards) Rules, 2021, as amended from time to time and other accounting principal generally accepted in India. 3. The figures for the Half year ended March 31, 2024 are the balancing figures between audited figures in respect of year ended March 31, 2024 and figures for the half year ended September 30, 2023. 4. The company is engaged primarily in the business of Operating Multi Speciality Hospitals and all its operations are in India only. Accordingly, there is no separate reportable segment as per AS 17 on “Segment Reporting” in respect of Company. 5. The Company applied to National Stock Exchange of India Limited (“NSE”) for in-principle approval for listing its equity shares on the Emerge Platform of the NSE. National Stock Exchange of India Limited has, vide its letter dated June 1, 2023 granted it’s In Principle Approval to the Company. The Company had filed Prospectus to the Registrar of the Company, Ahmedabad on June 13, 2023.The Public Issue was opened on Monday, June 19, 2023 and closed on Wednesday, June 21, 2023. The Basis of Allotment was finalized by Company, Registrar to the issue and merchant banker in consultation with the NSE on June 26, 2023. The Company has applied for listing of its total equity shares to NSE and it has granted its approval vide its letter dated June 28, 2023. The trading of equity shares of the Company commenced w.e.f. June 30, 2023 at Emerge Platform of National Stock Exchange of India Ltd. (NSE). The details of utilisation of the IPO Proceeds as below upto 30/09/2024. Notes: (i) The Board of Directors of the Company sought an approval of the Members by way of Special Resolution dtd. July 03, 2024 for variation in terms of the Object of the issue of the prospectus dtd. June 13, 2023, for utilising IPO proceeds amounting to Rs. 913.11 Lakhs for Working capital requirements of the company in lieu of Purchase of medical equipments for hospitals and/or newly acquired or set up hospitals. (ii) The Special Resolution proposed for Members approval for variation in terms of the Object of the issue of the prospectus for utilising IPO Proceeds by way of Postal Ballot Notice Dtd. May 25, 2024 through remote e-voting. (iii) The remote e-voting for Members' approval by way of Special Resolution proposed was remained open for a period of thirty days which was commenced at 9:00 A.M. on Tuesday, June 4, 2024 and ended on 5:00 P.M. on Wednesday, July 3, 2024. (iv) The Special Resolution proposed as mentioned above was approved by Members with majority. (v) A Scrutinizer's report dtd. July 05, 2024, i.e. outcome of e-voting Results, was submitted by the Company to NSE on July 05, 2024, in compliance with the Listing Agreement. (vi) The Company has kept the unutilised amount of IPO Proceeds as mentioned above as FDR with the Bank for the period ended September 30, 2024. Other Expenses 43570000.00 113000000.00 384886000.00 0.00 497886000.00 0.00 0.00 10068000.00 8353000.00 0.00 0.00 0.00 18421000.00 90119000.00 0.00 3750000.00 1116000.00 4061000.00 99046000.00 615353000.00 124921000.00 0.00 56423000.00 0.00 0.00 0.00 181344000.00 0.00 0.00 0.00 0.00 0.00 181344000.00 0.00 6070000.00 223002000.00 7789000.00 108334000.00 80354000.00 8460000.00 434009000.00 615353000.00 1. The above standalone financial results of the company (“the statement”) have been reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at its Meeting held on November 12, 2024 and have been subjected to limited review by the statutory auditors of the company on which the auditors have been expressed an unmodified Opinion. 2. The Standalone Financial results has been prepared in accordance with recognition and measurement principles laid down in the Accounting Standard 25 “Interim Financial Reporting” (As 25) as prescribed under section 133 of the companies act, 2013 (“the Act”) read with the companies (accounting standards) Rules, 2021, as amended from time to time and other accounting principal generally accepted in India. 3. The figures for the Half year ended March 31, 2024 are the balancing figures between audited figures in respect of year ended March 31, 2024 and figures for the half year ended September 30, 2023. 4. The company is engaged primarily in the business of Operating Multi Speciality Hospitals and all its operations are in India only. Accordingly, there is no separate reportable segment as per AS 17 on “Segment Reporting” in respect of Company. 5. The Company applied to National Stock Exchange of India Limited (“NSE”) for in-principle approval for listing its equity shares on the Emerge Platform of the NSE. National Stock Exchange of India Limited has, vide its letter dated June 1, 2023 granted it’s In Principle Approval to the Company. The Company had filed Prospectus to the Registrar of the Company, Ahmedabad on June 13, 2023.The Public Issue was opened on Monday, June 19, 2023 and closed on Wednesday, June 21, 2023. The Basis of Allotment was finalized by Company, Registrar to the issue and merchant banker in consultation with the NSE on June 26, 2023. The Company has applied for listing of its total equity shares to NSE and it has granted its approval vide its letter dated June 28, 2023. The trading of equity shares of the Company commenced w.e.f. June 30, 2023 at Emerge Platform of National Stock Exchange of India Ltd. (NSE). The details of utilisation of the IPO Proceeds as below upto 30/09/2024. Notes: (i) The Board of Directors of the Company sought an approval of the Members by way of Special Resolution dtd. July 03, 2024 for variation in terms of the Object of the issue of the prospectus dtd. June 13, 2023, for utilising IPO proceeds amounting to Rs. 913.11 Lakhs for Working capital requirements of the company in lieu of Purchase of medical equipments for hospitals and/or newly acquired or set up hospitals. (ii) The Special Resolution proposed for Members approval for variation in terms of the Object of the issue of the prospectus for utilising IPO Proceeds by way of Postal Ballot Notice Dtd. May 25, 2024 through remote e-voting. (iii) The remote e-voting for Members' approval by way of Special Resolution proposed was remained open for a period of thirty days which was commenced at 9:00 A.M. on Tuesday, June 4, 2024 and ended on 5:00 P.M. on Wednesday, July 3, 2024. (iv) The Special Resolution proposed as mentioned above was approved by Members with majority. (v) A Scrutinizer's report dtd. July 05, 2024, i.e. outcome of e-voting Results, was submitted by the Company to NSE on July 05, 2024, in compliance with the Listing Agreement. (vi) The Company has kept the unutilised amount of IPO Proceeds as mentioned above as FDR with the Bank for the period ended September 30, 2024. 3746000.00 4709000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8455000.00 340000.00 -16834000.00 -14431000.00 -9451000.00 499000.00 -1216000.00 -41093000.00 -32638000.00 -29357000.00 0.00 0.00 0.00 0.00 0.00 -29357000.00 0.00 0.00 -29357000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4262000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -4262000.00 0.00 0.00 -4262000.00 0.00 0.00 0.00 0.00 2335000.00 0.00 3746000.00 0.00 47732000.00 41651000.00 0.00 0.00 41651000.00 8032000.00 0.00 8032000.00 108091000.00 116123000.00